Salarius Pharmaceuticals (SLRX)
(Delayed Data from NSDQ)
$0.50 USD
-0.01 (-1.77%)
Updated Apr 25, 2024 03:53 PM ET
After-Market: $0.48 -0.02 (-3.81%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -6.70 |
EPS Last Quarter | -0.22 |
Last EPS Surprise | 78.22% |
ABR | 3.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -26.80 |
Next Year | -23.50 |
EPS (TTM) | -4.53 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -6.70 | -6.70 | -26.80 | -23.50 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -6.70 | -6.70 | -26.80 | -23.50 |
High Estimate | -6.70 | -6.70 | -26.80 | -23.50 |
Low Estimate | -6.70 | -6.70 | -26.80 | -23.50 |
Year ago EPS | -2.23 | -1.43 | -3.84 | -26.80 |
Year over Year Growth Est. | -200.45% | -368.53% | -597.92% | 12.31% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -6.70 | -6.70 | -26.80 | -23.50 |
7 Days Ago | -6.70 | -6.70 | -26.80 | -23.50 |
30 Days Ago | -1.15 | -1.16 | -4.63 | -4.06 |
60 Days Ago | -0.80 | -0.75 | -3.02 | -2.76 |
90 Days Ago | -0.80 | -0.75 | -3.02 | -2.76 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -6.70 | -6.70 | -26.80 | -23.50 |
Zacks Consensus Estimate | -6.70 | -6.70 | -26.80 | -23.50 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.22 | -0.65 | -1.43 | -2.23 | NA |
Estimate | -1.01 | -1.07 | -1.26 | -1.98 | NA |
Difference | 0.79 | 0.42 | -0.17 | -0.25 | 0.20 |
Surprise | 78.22% | 39.25% | -13.49% | -12.63% | 22.84% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more